Research Progress

[04-06-2019]Researchers suggest the F-Fc protein being a safe and effective RSV vaccine candidate

In a recent study, the research group led by Prof. XIAO Gengfu in Wuhan Institute of Virology of the Chinese Academy of Sciences developed a novel vaccine antigen, RSV glycoprotein F fused with an IgG Fc fragment (F-Fc).

[04-06-2019]Scientists provide the first demonstration of the NTPase/helicase-like activity encoded by EBOV

In a recent study, the research group led by Prof. ZHOU Xi in Wuhan Institute of Virology of the Chinese Academy of Sciences reported for the first time that the EBOV-encoded multifunctional protein VP35 has NTPase and helicase-like activities that can bind to NTPs, hydrolyze all types of NTPs and unwind RNA helices in an NTP-dependent manner.

[13-05-2019]Chinese Researchers Identify a Novel Regulator of STAT3 activity, Th17 differentiation and CAC de...

In a joint study with Prof. XIA Huimin from Guangzhou Women and Children’s Medical Center, Prof. WANG Yanyi from Wuhan Institute of Virology of the Chinese Academy of Sciences, has identified a molecule, called FAM64A, as a positive regulator of STAT3 activity. They performed a large-scale screen to identify candidate proteins that regulate STAT3 activity by reporter assays, and found that FAM...

[22-04-2019]Scientists design a training program for BSL-4 laboratory users

In a recent study, the team led by Prof. YUAN Zhiming in Wuhan Institute of Virology of the Chinese Academy of Sciences designed a training program for BSL-4 laboratory users that follows local, national, and international guidelines and regulations. Their program ensures the safety and security of staff involved in research at the Wuhan BSL-4 laboratory.